Benzofuran compound, composition thereof, kit thereof, and/or method thereof. A benzofuran-2-carboxamide moiety may be N-arylated and/or N-alkylated, and the resulting benzofuran compound may be a sigma receptor ligand that binds to, e.g., a σ1 receptor and/or a σ2 receptor with relatively high affinity and/or selectivity. For example, the benzofuran compound may be 5,6-dimethoxy-3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide, 3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide, or 6-methoxy-3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide. The composition may include the benzofuran compound and a pharmaceutically acceptable carrier.
苯并呋喃化合物、其组成物、套件以及/或方法。
苯并呋喃-2-羧酰胺基团可以被N-芳基化和/或N-烷基化,从而产生的
苯并呋喃化合物可以是与σ1受体和/或σ2受体具有相对高亲和力和/或选择性的σ受体
配体。例如,
苯并呋喃化合物可以是5,6-二甲氧基-3-甲基-N-苯基-N-(3-
哌啶基)丙基)
苯并呋喃-2-羧酰胺、3-甲基-N-苯基-N-(3-
哌啶基)丙基)
苯并呋喃-2-羧酰胺或6-甲氧基-3-甲基-N-苯基-N-(3-
哌啶基)丙基)
苯并呋喃-2-羧酰胺。该组成物可以包括
苯并呋喃化合物和药学上可接受的载体。